AKT signaling is frequently dysregulated in the triple negative breast cancer subtype, since AKT signaling is involved in the regulation of several cancer hallmarks such as survival, metabolisms, cell motility, and metastasis [29,35]. This evidence concerns the gene AKT1 and triple-negative breast carcinoma.